Therapixel receives FDA 510(k) clearance for MammoScreen™
- Thursday, July 9, 2020, 7:14
- Environment
- Add a comment
PARIS, July 9, 2020 /PRNewswire/ — MammoScreen™, the explainable and actionable artificial intelligence (AI) based software assisting Radiologists in reading screening mammograms, received 510(k) clearance K192854 from the U.S. Food and Drug Administration (FDA). This FDA clearance was…
About the Author
adminasapcorp has written 41769 stories on this site.